If you could vote on Brexit now which option would you choose?
   

Drug distributor McKesson seen getting likely boost from COVID vaccine demand


McKesson Corp is expected to report strong earnings on Wednesday as an Omicron-driven surge in demand for COVID-19 vaccines and tests is likely to insulate the drug distributor from tepid sales of other medical products. The unit which sells medical and surgical products contributes about 5% to McKesson's revenue, compared with rival Cardinal Health Inc's similar business accounting for 10%. A surge in COVID-19 cases due to the fast-spreading Omicron variant has overwhelmed hospitals, forcing them to turn away patients seeking less-urgent procedures.

Reuters - February 3, 2022

View the full story here: https://www.reuters.com/business/healthcare-pharmaceuticals/drug-distributor-mckesson-seen-getting-likely-boost-covid-vaccine-demand-2022-02-02/